CHEST Journal Podcasts American College of Chest Physicians

Mira M. John, MD, and Başak Çoruh, MD, join CHEST Podcast Moderator Gretchen Winter, MD, to discuss postinterview communication practices among fellowship applicants and program directors.

Janani S. Reisenauer, MD; Patrick W. Eiken, MD; and Dawn Owen, MD PhD, join journal CHEST Podcast Moderator Dominique Pepper, MD, to discuss new research comparing outcomes for metastasis-directed therapies including sublobar resection, stereotactic body radiation therapy, and percutaneous ablation.

CHEST® journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the April 2024 issue, including studies into predictors of treatment response to bronchial thermoplasty, individual risk factors that may influence the effect of acute outdoor air pollution on outcomes in individuals with COPD, and urban-rural differences in mortality rates for individuals with idiopathic pulmonary fibrosis.
https://journal.chestnet.org/issue/S0012-3692(23)X0006-3

CHEST April 2024, Volume 165, Issue 4
Elizabeth S. Munroe, MD, joins CHEST Podcast Moderator Dominique Pepper, MD, to discuss the use of vasopressors in routine practice and potential associations between vasopressor initiation route and in-hospital mortality.
DOI: https://doi.org/10.1016/j.chest.2023.10.027
 
Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

CHEST April 2024, Volume 165, Issue 4
Sonia Graziano, PsyD, joins CHEST Podcast Moderator Gretchen Winter, MD, to discuss how elexacaftor/tezacaftor/ivacaftor affects mental health, cognitive processing, neuropsychological side effects, GI symptoms, and health-related quality of life in people with cystic fibrosis.
DOI: https://doi.org/10.1016/j.chest.2023.10.043
 
Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

CHEST journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key articles published in the CHEST March 2024 issue.